Orange Book product · Brand (NDA)

ZINGO

LIDOCAINE HYDROCHLORIDE

Brand (NDA)NDA 022114RX POWDER PHARMS

Aug 16, 2007

Approved

Brand (NDA)

Application

Not listed

TE code

Listed patents

Approval
FDA approval date of this drug product.
Aug 16, 2007
19 yr 1 mo ago
Today
Patent 8540665 expires
Listed method-of-use patent (U-1438) expiration.
Oct 22, 2029
in 3 yr 5 mo
Patent 9358338 expires
Listed method-of-use patent (U-1870) expiration.
Apr 27, 2035
in 9 yr
Patent 9370622 expires
Listed method-of-use patent (U-1870) expiration.
Sep 28, 2035
in 9 yr 5 mo

Active ingredient

LIDOCAINE HYDROCHLORIDE

Strength

0.5MG

Dosage form

SYSTEM

Route

INTRADERMAL

TE code

Not listed

Application

NDA 022114

Product number

001

Marketing status

Reference listed drug (RLD)

Reference standard (RS)

Active-ingredient family

This is a brand (NDA) product. Other products sharing this active ingredient are listed below.

Patents listed in the FDA Orange Book for this product, with expiration date and patent type.
Patent	Expires	In	Type
8540665	Oct 22, 2029	in 3 yr 5 mo	U-1438
9358338	Apr 27, 2035	in 9 yr	U-1870
9370622	Sep 28, 2035	in 9 yr 5 mo	U-1870